European Companies Search Engine
Wordmark: “MODIVITY“ Euipotm 23 Dec 2021 European Union Intellectual Property Office (Trade Marks)
History
Text
Trade mark
| Type | Word |
| Name | MODIVITY |
| Filing number | 018544121 |
| Trade mark status | REGISTERED |
| Nice Classification |
40: Treatment of materials for others, namely processing and transforming of pharmaceutical preparations used in the field of gene, cell immunotherapies and transplantation.. 42: Medical and scientific research and development of gene and cellular immunotherapies and transplantation; providing temporary use of non-downloadable software applications accessible via a website that enables users to remotely manage, administer, modify and control their end user computer devices and software applications to implement, schedule, control, track, monitor, manage, process, analyze and record medical and laboratory procedures for patients and shipment and transmission of patient medical information, laboratory samples, diagnostic medical samples and clinical medical samples; medical laboratory services, all of the foregoing relating to gene and cellular immunotherapies and transplantation.. 44: Medical services, namely in the field of gene and cellular immunotherapies and transplantation and medical diagnostic testing, monitoring and reporting services; medical treatment services; blood testing, and blood treatment and processing for the purpose of medical clinical diagnosis; consulting services in the fields of medical treatment and medicines, medical diagnostic testing, and diagnostic and clinical blood treatment procedure; human cell and tissue banking services; collection and preservation of human blood and cells for medical use; hosting a patient support call center regarding gene and cellular immunotherapies and transplantation.. |
| Filing date | 31/08/2021 |
| Registration date | 21/12/2021 |
| Expiry date | 31/08/2031 |
| Owners |
c/o Novartis Pharma AG Trademark Department CH-4002 Basel Switzerland |
The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Novartis AG, Basle, Switzerland.